The expansion addresses a long-standing barrier for patients who previously traveled significant distances for the FDA-cleared silicone implant. By establishing regional hubs in cities like Dubai, Riyadh, and Istanbul, the company aims to facilitate local consultations and consistent postoperative support. Dr. Elist noted that decentralized care allows patients to navigate the procedure in their preferred language while selecting destinations that align with their personal financial and travel constraints.

To manage this growth, the company launched an interactive digital portal that catalogs participating surgeons, pricing structures, and logistical guidance. Prospective patients can use the platform to coordinate travel, including flight and accommodation planning, alongside their clinical timelines. Looking ahead, Himplant plans to enter the South American market by the end of 2026, with target launches in Argentina, Brazil, and Peru pending physician certification and facility compliance. The company is currently developing regional education programs to standardize clinical outcomes as the network scales.